Avalo Therapeutics Price Chart
Avalo Therapeutics Volume Chart
Avalo Therapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
+0.05(+0.36%)
| Open | $13.95 |
|---|---|
| Close | $14.00 |
| Low | $13.95 |
| Low Change | 0.00 (0.00%) |
| High | $14.00 |
| High Change | +0.05 (+0.36%) |
| Range | $0.05 |
| Volume | 12.106K |
| Dollar Volume | $169.48K |
Regular Trading Hours Yesterday
+0.10(+0.72%)
| Open | $13.80 |
|---|---|
| Close | $13.90 |
| Low | $13.59 |
| Low Change | -0.21 (-1.52%) |
| High | $14.46 |
| High Change | +0.66 (+4.78%) |
| Range | $0.87 |
| Volume | 828.332K |
| Dollar Volume | $11.51M |
Premarket Yesterday
*No Trades in Segment
Avalo Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $13.65 |
|---|---|
| 10 Day Moving Average (SMA10) | $14.42 |
| 20 Day Moving Average (SMA20) | $15.99 |
| 50 Day Moving Average (SMA50) | $15.55 |
| 100 Day Moving Average (SMA100) | $16.53 |
| 200 Day Moving Average (SMA200) | $12.95 |
Avalo Therapeutics Statistics
| Average Volume (30 Days) | 692.22K |
|---|---|
| P/E Ratio (Current) | -2.59 |
| EPS (Current) | -$5.39 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 3.38 |
| Current Ratio | 14.27 |
| Quick Ratio | 14.27 |
| Debt to Equity | 0.00 |
| Enterprise Value | $231.29M |
| EV to EBITDA | -3.50 |
| EV to Sales | 1204.64 |
| Price to Book | 2.82 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 1345.07 |
| Return on Assets | -0.80% |
| Return on Equity | -1.09% |
Avalo Therapeutics Stock Splits
There have been 3 stock splits for Avalo Therapeutics (AVTX). The last reverse stock split occured on December 29, 2023 and reduced the outstanding shares at a ratio of 240:1.
| Date | Type | Ratio |
|---|---|---|
| Dec 29, 2023 | Reverse | 240:1 |
| Jul 8, 2022 | Reverse | 12:1 |
| Sep 10, 2007 | Reverse | 51:1 |
Avalo Therapeutics Dividends
There have been no dividends for Avalo Therapeutics (AVTX).